Navigation Links
Trends in Treatment of America's Wounded Warriors
Date:11/8/2007

Psychological Traumas and Traumatic Brain Injuries: The Signature Wounds of Operation Iraqi Freedom and Operation Enduring Freedom

WASHINGTON, Nov. 8 /PRNewswire-USNewswire/ --- Veterans for America's "Trends in Treatment of America's Wounded Warriors" identifies a number of interrelated trends adversely affecting servicemembers and veterans suffering from the "signature wounds" of Iraq and Afghanistan - traumatic brain injury (TBI) and psychological traumas.

This report is the result of VFA's aggressive investigative program which identifies deficiencies in the treatment of service-connected neurological and/or mental health problems.

VFA investigators have visited every demobilization site in the United States and overseas, where they have monitored the quality of treatment, family support, rehabilitation, and other services that should enable a wounded servicemember to readjust to civilian life.

VFA has found that medical care for mental health and TBI is often inadequate or poorly delivered, and when a servicemember is discharged, decisions are often made by the military that negatively affect veterans for the rest of their lives.

VFA has also found that little consideration is given to TBI or PTSD in the military justice system despite the fact that these wounds are known to cause improper behavior.

Lack of capabilities to treat these injuries, inadequate adherence to the Congressional inquiry process, and the inability or unwillingness to treat PTSD and TBI as wounds of equal legitimacy as physical injuries are some problems that require improved military leadership.

This report incorporates VFA investigative findings with open-source DoD and other reports and articles to provide a comprehensive picture of the state of care for America's wounded warriors.

According to retired Brigadier General Dr. Stephen N. Xenakis, former Commanding General of the Southeast Regional Army Medical Command: "VFA's r
'/>"/>

SOURCE Veterans for America
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Segal Survey Predicts Declines in Trends for Fifth Consecutive Year
2. Watson Wyatt Identifies Major Benefit Trends During Open Enrollment Season
3. Wyeth Comments on PREVNAR and Trends in Pneumococcal Disease
4. Case in Point Magazine Releases 2007 Case Management Salary and Trends Survey
5. Neurotechnology Industry Organization Unveils Top 10 Neuroscience Trends of 2007
6. New treatment effective in counteracting cocaine-induced symptoms
7. New treatment boosts muscle function in myasthenia gravis
8. Broad-based group of physicians calls for improvement in stroke treatment
9. Cranberry Could Juice Up Ovarian Cancer Treatment
10. Non-medicinal treatment touted for pre-schoolers with ADHD
11. Nonmedicinal treatment touted for preschoolers with ADHD
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:Task Force Recommends Against Screening for Chronic Obstructive Pulmonary Disease Using Spirometry 2Health News:Task Force Recommends Against Screening for Chronic Obstructive Pulmonary Disease Using Spirometry 3Health News:Ronnie B. Martin, DO, FACOFP-dist. to be Inaugurated as the 55th President of the ACOFP (2008-2009) 2Health News:Ronnie B. Martin, DO, FACOFP-dist. to be Inaugurated as the 55th President of the ACOFP (2008-2009) 3Health News:Researchers identify new genetic marker for breast cancer 2Health News:Woman Sues DuPont and Asbestos Manufacturers After Developing Mesothelioma From Exposure to Asbestos in Husband's Work Clothes 2Health News:Cold Spring Harbor Protocols features high-throughput methods for analyzing gene activity 2Health News:Folic Acid in the Food Supply Reduces Birth Defects, but May Cause Extra Cancers, Reports the Harvard Women's Health Watch 2
Breaking Medicine Technology:Sangart, Inc. Initiates Phase IIa Study of Oxygen Therapeutic Agent MP4OX in Severe Trauma Patients With Hemorrhagic Shock 2Sangart, Inc. Initiates Phase IIa Study of Oxygen Therapeutic Agent MP4OX in Severe Trauma Patients With Hemorrhagic Shock 3Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 2Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 3Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 4Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 5Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 6Press conference schedule announced for TCT 2009 55559 1Press conference schedule announced for TCT 2009 55559 2Unique study isolates DNA from Linnaeus botanical collections 9719 1Phoenix Cardiovascular Surgeon David J Caparrelli M D Becomes Member of the Society for Vascular Surgery 55552 1Phoenix Cardiovascular Surgeon David J Caparrelli M D Becomes Member of the Society for Vascular Surgery 55552 2Phoenix Cardiovascular Surgeon David J Caparrelli M D Becomes Member of the Society for Vascular Surgery 55552 3